Fostering Culture,
Inspiring Performance,
Encouraging Teamwork
Management Team
A.J. Kazimi
Chief Executive Officer
Mr. Kazimi is the Chairman of our Board of Directors and Chief Executive Officer who founded Cumberland in 1999. His career includes over 30 years in the biopharmaceutical industry. At Cumberland, he has overseen the development and FDA approval of key Company brands, while also leading the acquisition of the Company’s other commercial products. He was responsible for Cumberland’s initial public offering and listing on the Nasdaq stock exchange. Mr. Kazimi also serves as Chairman and Chief Executive of Cumberland Emerging Technologies, a joint initiative with Vanderbilt University and the state of Tennessee, designed to support the development of early-stage life sciences programs and companies. Prior to joining Cumberland, he spent eleven years helping to build Therapeutic Antibodies Inc., an international biopharmaceutical company. As President and Chief Operating Officer, he made key contributions to that company’s growth from its start-up phase through its initial public offering and listing on the London stock exchange. Mr. Kazimi started his career at Brown-Forman Corporation, rising through a series of management positions. He is Chairman of the Board for the Gettysburg Foundation which partners with the National Park Service to preserve that historic military park. He is also a member of the Board of the Tennessee Historical Society. He previously served on the Board of Directors for the Nashville Health Care Council, an association of the largest concentration of healthcare companies in the U.S. and the Board of Aegis Sciences Corporation, a federally certified forensic toxicology laboratory, which has sold twice to large private equity investors. Mr. Kazimi holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt University Owen Graduate School of Management. The Board believes that Mr. Kazimi brings strategic insight, leadership and a history of successful execution to the Board along with a wealth of experience in both the biopharmaceutical industry and the development of emerging companies.
James L. Herman
Executive Vice President
National Accounts and
Chief Compliance Officer
Mr. Herman handles all our national accounts sales, including wholesalers and retail chain buying offices, managed care home offices and federal government accounts. He is also charged with overseeing our corporate compliance efforts. He has been with us since 2003 and has over 30 years of pharmaceutical industry experience. He previously served as Director of Managed Care and Director of Trade Affairs and Customer Service at Solvay Pharmaceuticals. Prior to that Mr. Herman was with Schwarz Pharma, where he held national sales leadership positions in National Accounts and Managed Care. He holds a B.S. from Indiana University and an M.B.A. from Cardinal Stritch University.
John M. Hamm
Vice President and Chief Financial Officer
Mr. Hamm is responsible for Cumberland’s financial systems, and reporting. He also oversees the Company’s business development and legal activities. Mr. Hamm has over 25 years of finance, accounting and operations experience in several industries, with a majority in health care. He previously held the positions of Chief Operating Officer and Chief Financial Officer, Pharmacy at HealthSpring, Inc., a managed care organization currently operating as Cigna-HealthSpring. Prior to that he was Vice President Finance at Emdeon Business Services. Emdeon Inc., a healthcare technology firm that now operates as Change Healthcare Inc., is a Nasdaq listed company with over $3 billion in annual revenue. Mr. Hamm has a B.S. in Business Administration with a minor in Accounting from Wheeling University. He earned his M.B.A. with an emphasis in Accounting from West Virginia University. He is a Certified Management Accountant (CMA) and Certified Financial Manager (CFM).
Todd M. Anthony
Vice President
Organizational Development
Mr. Anthony manages our human resources, information technology and cybersecurity, organizational development and office administration activities. Mr. Anthony has been with Cumberland since 2010. During his tenure, he has made many contributions to training and development initiatives as well as human resources activities. These include the preparation and implementation of sales training materials for each branded product. Under his leadership, the Cumberland Academy was established with a core curriculum and advanced courses designed to provide industry expertise and continued learning opportunities for the office employees. He has over 30 years of pharmaceutical training, development and human resource management experience. Prior to joining Cumberland, he held various positions of increasing responsibilities at Berlex Laboratories Inc. and spent 19 years at that company which is now Bayer HealthCare Pharmaceuticals following the 2006 acquisition of Schering AG. Mr. Anthony holds a B.S. in Nursing from D’Youville College in Buffalo, NY.
Tan Cheow Choon
Senior Director
International Business
Mr. Cheow Choon is the Senior Director of International Business Development for Cumberland Pharmaceuticals. His responsibilities include identifying new partnership opportunities and managing those relationships in the Asian market. Prior to joining Cumberland, Mr. Choon was Vice President of Southeast Asia & Korea at Hospira Inc. His career also includes roles in banking and finance with the United Overseas Bank, Singapore as well as the establishment, development and management of pharmaceutical partnerships across Asia as General Manager, Asia for Mayne & Faulding Pharmaceutical of Australia. Mr. Choon holds an M.B.A. from Monash University in Australia and is an accountant earning his bachelor’s degree in accountancy from the National University of Singapore.
Chris T. Bitterman
Vice President
Sales and Marketing
Mr. Bitterman joined Cumberland following a distinguished career in Acute Care and pharmaceutical sales management spanning over 25 years. Highlights include his roles as National Sales Director for Lupin Pharmaceuticals, Daiichi Sankyo and Regional Sales Director for Sanofi Aventis, all of which are pharmaceutical manufacturing companies. At Cumberland, Mr. Bitterman first served as the Hospital Sales Director, leading the Hospital Sales division. Mr. Bitterman’s role then expanded to include the Oncology Business, and he was promoted to Senior Director of Hospital and Oncology Sales. Currently, Mr. Bitterman is the Vice President of Sales & Marketing, where he is responsible for leading the sales and marketing efforts for Cumberland’s commercial portfolio and delivering annual financial objectives. Mr. Bitterman earned his B.S and M.B.A. degrees from Central Michigan University.
Ines Macias-Perez, Ph.D.
Director
Product Development
Dr. Macias-Perez, Ph.D., is a clinical research professional with extensive experience in drug development and program management. In her role as the Director of Product Development at Cumberland Pharmaceuticals, she oversees the strategic planning, execution, and management of clinical and nonclinical programs for the Company’s product portfolio. Prior to her role at Cumberland, Dr. Macias-Perez held leadership positions at the Radiosurgical Research Institute, where she served as the Executive Director, and Berg Pharma, where she was the Clinical Research Director. She also held positions at renowned institutions Sarah Cannon Research Institute and Vanderbilt University, where she conducted cancer research. Her expertise spans strategic product innovation, tactical regulatory approaches and identifying unmet medical needs. Dr. Macias-Perez has made significant contributions to the field of oncology and rare disease research, with numerous publications and presentations at national conferences. She has also received grants from the FDA Orphan Product Division for clinical trials as well as several honors and awards from Cumberland Pharmaceuticals, including the President’s Award. She holds a Ph.D. from Vanderbilt University in Cancer Biology and an M.S. and B.A. from the University of South Florida.
Adam S. Mostafa
Managing Director
Banking and Investor Relations
In his role as consulting Managing Director of Banking and Investor Relations, Mr. Mostafa is responsible for managing our investment banking activities and supporting our institutional investor interactions. He is an experienced biopharmaceutical investment banker who has worked in corporate finance since 2001. Prior to joining Cumberland in 2017, Mr. Mostafa worked on Wall Street at Cantor Fitzgerald & Co. as Managing Director, Healthcare Investment Banking. There, he was involved predominantly in financing life sciences companies in the specialty pharmaceutical and biotechnology sectors. Mr. Mostafa also served as a Senior Health Care Investment Banker at both Needham & Company and CRT Capital, where, at the latter, he was also involved in life sciences private equity investments. Earlier in his career, Mr. Mostafa was a portfolio management associate at AQR Capital and a Health Care Investment Banking Analyst at Salomon Smith Barney. He graduated from Brown University with a B.A. in economics.